Elizabeth F. Lindquist is a partner in the FDA & Life Sciences Practice in King & Spalding’s Washington, D.C., office. Her practice focuses on regulatory and enforcement issues relating to federal health care agencies and programs, including the Department of Veterans Affairs Federal Supply Schedule Program, the Centers for Medicare & Medicaid Services, the Health Resources and Services Administration, the TRICARE Program, and the U.S. Food and Drug Administration.
Elizabeth has significant experience counseling clients on complex regulatory and compliance issues related to pharmaceutical manufacturer government price calculation and reporting practices.
Elizabeth graduated from the Saint Louis University School of Law in 2009, where she received a Dean’s Scholarship, a Certificate in Health Law Studies, and was the Editor-in-Chief of the Saint Louis University Journal of Health Law & Policy. Elizabeth graduated from Williams College in 2005 with a Bachelor of Arts with Honors in Biology and History. At Williams, Elizabeth completed an Honors thesis in Biology and was an All-American softball player.
Prior to attending law school, Elizabeth worked as a Clinical Research Coordinator at the Hospital for Special Surgery in New York, New York. In this position she ensured that clinical research protocols complied with Institutional Review Board requirements and all applicable federal and state laws and regulations. Elizabeth also gained experience filing regulatory submissions with the FDA and served as the liaison between clinical investigators and the Hospital’s Legal Department.
- Food and Drug Law Institute Update Editorial Advisory Board
- American Bar Association
- American Health Lawyers Association
- District of Columbia Bar Association
- J.D., Saint Louis University
- B.A., Williams College
- District of Columbia
- New York
Rate : $$$